MAY 27, 2025 AT 06:05 AM
Additional European Equity News
Source
SectionEuropean Equities
AstraZeneca (AZN LN) - AstraZeneca’s Imfinzi has been recommended for approval in the EU for bladder cancer, with the company noting it was well tolerated and no new safety signals were observed.
DCC (DCC LN) - Launch of GBP 100mln share buyback. (Newswires)
Sanofi (SAN FP) - Co. launches vaccine factory in Vietnam. (Newswires)
Serco (SRP LN) - Completed acquisition of MTS. Outlook 2025: Revenue of around GBP 4.8bln. Adverse translation impact of currency movements for 2025 exp. to be around GBP 90mln for rev. and GBP 7mln for underlying op. profit. (Newswires)
Whitbread (WTB LN) - Hodgson appointed as Chair of Co. (Newswires)
FLSmidth (FLS DC) upgraded to Buy from Neutral at Goldman Sachs